Subretinal fluid left over after anti-VEGF treatment may be associated with better best corrected visual acuity, according to a study.
“Our meta-analysis sought to explore the association between subretinal or intraretinal fluid and best corrected visual acuity in neovascular age-related macular degeneration patients undergoing anti-VEGF therapy,” Peter J. Kertes, MD, told Healio/OSN.
Kertes and colleagues searched the literature for studies that reported on visual acuity stratified by the presence of any residual subretinal fluid (SRF), intraretinal fluid (IRF) or any retinal fluid